<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="CAD" hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-109151-001</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">G protein functional selectivity in metabolic disorders</narrative>
   <narrative xml:lang="FR">S&#xE9;lectivit&#xE9; fonctionnelle de la prot&#xE9;ine G dans les troubles m&#xE9;taboliques</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Le diab&#xE8;te de type 2 est une maladie m&#xE9;tabolique caract&#xE9;ris&#xE9;e par des taux de sucre &#xE9;lev&#xE9;s dans le sang qui r&#xE9;sultent d&#x2019;une r&#xE9;duction de la s&#xE9;cr&#xE9;tion d&#x2019;insuline par les cellules b&#xEA;ta du pancr&#xE9;as et d&#x2019;une sensibilit&#xE9; r&#xE9;duite &#xE0; l&#x2019;insuline. Les traitements actuels sont efficaces pour faire dispara&#xEE;tre de nombreux sympt&#xF4;mes, mais ils n&#x2019;arr&#xEA;tent pas la progression du dysfonctionnement m&#xE9;tabolique. Par cons&#xE9;quent, la grande majorit&#xE9; des patients diab&#xE9;tiques mourront d&#x2019;une crise cardiaque ou d&#x2019;un accident vasculaire c&#xE9;r&#xE9;bral, et la maladie demeure la principale cause de c&#xE9;cit&#xE9;, d&#x2019;insuffisance r&#xE9;nale et d&#x2019;amputations non traumatiques. Il est urgent de mettre au point de nouveaux traitements. 

Des &#xE9;tudes g&#xE9;n&#xE9;tiques et fonctionnelles ont permis de d&#xE9;couvrir les r&#xE9;cepteurs coupl&#xE9;s aux prot&#xE9;ines G (RCPG) et les r&#xE9;gulateurs de la signalisation des prot&#xE9;ines G exprim&#xE9;es dans les cellules b&#xEA;ta comme cibles potentielles pour le d&#xE9;veloppement de nouveaux traitements. La valeur du traitement cibl&#xE9; par RCPG pour le diab&#xE8;te de type 2 a &#xE9;t&#xE9; d&#xE9;montr&#xE9;e par des m&#xE9;dicaments ciblant le r&#xE9;cepteur GLP1, mais divers effets secondaires accompagnent leur utilisation, notamment des naus&#xE9;es, des &#xE9;pisodes hypoglyc&#xE9;miques et l&#x2019;absence de restauration &#xE0; long terme de la fonction des cellules b&#xEA;ta. Une cause sous-jacente de ces effets ind&#xE9;sirables est li&#xE9;e au fait que chaque RCPG peut engager plusieurs voies de signalisation qui sont responsables de leurs diff&#xE9;rentes actions. Les progr&#xE8;s r&#xE9;cents des &#xE9;tudes sur les RCPG ont r&#xE9;v&#xE9;l&#xE9; qu&#x2019;il devrait &#xEA;tre possible de concevoir des m&#xE9;dicaments qui r&#xE9;gulent de fa&#xE7;on s&#xE9;lective les voies th&#xE9;rapeutiques pertinentes tout en &#xE9;vitant celles qui produisent les effets nocifs. 

Pour ce faire, une meilleure compr&#xE9;hension des d&#xE9;terminants mol&#xE9;culaires contr&#xF4;lant les diff&#xE9;rentes voies engag&#xE9;es par un RCPG donn&#xE9; et ses prot&#xE9;ines G apparent&#xE9;es est n&#xE9;cessaire. En combinant la mod&#xE9;lisation in silico bas&#xE9;e sur la structure &#xE0; des essais biochimiques ou biophysiques, ce projet vise &#xE0; d&#xE9;terminer quels sont les partenaires prot&#xE9;iques et les d&#xE9;terminants de la fonction ou de la sp&#xE9;cificit&#xE9; pour sonder le r&#xF4;le des voies de signalisation individuelles engag&#xE9;es par le r&#xE9;cepteur GLP1 qui permettront de mettre au point des m&#xE9;dicaments plus efficaces contre le diab&#xE8;te de type 2. 

Ce projet a &#xE9;t&#xE9; retenu aux fins de financement au cours du cinqui&#xE8;me concours de recherche du Programme conjoint canado-isra&#xE9;lien de recherche en sant&#xE9;. Il s&#x2019;agit d&#x2019;un partenariat entre le CRDI, les Instituts de recherche en sant&#xE9; du Canada, l&#x2019;Israel Science Foundation et l&#x2019;Azrieli Foundation.</narrative>
   <narrative xml:lang="EN">Type 2 diabetes is a metabolic disease characterized by elevated circulating sugar levels that result from reduced insulin secretion from pancreatic beta cells and reduced sensitivity to insulin. Current treatments are effective in reversing many of the symptoms, but they do not stop the progression of the metabolic dysfunction. As a result, the vast majority of patients with diabetes will die from a heart attack or stroke, and the disease remains the main cause of blindness, kidney failure, and non-traumatic amputations. There is an urgent need to develop new treatments. 

Both genetic and functional studies have identified G protein-coupled receptors (GPCR) and regulators of G protein signaling expressed in beta cells as potential targets for the development of new treatments. The value of GPCR-targeted therapy for type 2 diabetes has been demonstrated by drugs targeting the glucagon-like peptide-1 (GLP1) receptor, but various side effects accompany their use, including nausea, hypoglycemic episodes, and no long-term restoration of beta cell function. An underlying cause of these undesirable effects relates to the fact that each GPCR can engage several signaling pathways that are responsible for their different actions. Recent progress in GPCR studies revealed that it should be possible to design drugs that selectively regulate the therapeutically relevant pathways while sparing those responsible for the adverse effects. 

For this purpose, a better understanding of the molecular determinants controlling the different pathways engaged by a given GPCR and its cognate G proteins is needed. Combining structure-based in-silico modelling with biochemical/biophysical assays, this project aims to identify protein partners and function/specificity determinants to probe the role of the individual signaling pathways engaged by the GLP1 receptor that will allow the development of more efficacious and safer drugs against type 2 diabetes. 

This project was selected for funding through the fifth research competition of the Joint Canada-Israel Health Research Program. This initiative is a partnership between IDRC, the Canadian Institutes of Health Research, the Israel Science Foundation, and the Azrieli Foundation.</narrative>
  </description>
  <participating-org role="1" type="24">
   <narrative xml:lang="EN">Azrieli Foundation</narrative>
  </participating-org>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Parlement</narrative>
   <narrative xml:lang="EN">Canada. Parliament</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <participating-org role="2" type="80">
   <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
  </participating-org>
  <participating-org role="4" type="80">
   <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-11-01" type="2"></activity-date>
  <activity-date iso-date="2022-11-01" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="2"></activity-scope>
  <recipient-country code="BR" percentage="34"></recipient-country>
  <recipient-region code="389" percentage="33" vocabulary="1"></recipient-region>
  <recipient-region code="589" percentage="33" vocabulary="1"></recipient-region>
  <sector code="1" percentage="100" vocabulary="99">
   <narrative xml:lang="FR">Autre</narrative>
   <narrative xml:lang="EN">Other</narrative>
  </sector>
  <sector code="12182" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-11-25"></transaction-date>
   <value currency="CAD" value-date="2019-11-25">166666</value>
   <provider-org>
    <narrative xml:lang="EN">Azrieli Foundation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-11-25"></transaction-date>
   <value currency="CAD" value-date="2019-11-25">166666</value>
   <provider-org>
    <narrative xml:lang="EN">Azrieli Foundation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-11-25"></transaction-date>
   <value currency="CAD" value-date="2019-11-25">503334</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-11-25"></transaction-date>
   <value currency="CAD" value-date="2019-11-25">503334</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-11-26"></transaction-date>
   <value currency="CAD" value-date="2019-11-26">27448</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-11-26"></transaction-date>
   <value currency="CAD" value-date="2019-11-26">82896</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">-27448</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">-82896</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">27448</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">82896</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-05-04"></transaction-date>
   <value currency="CAD" value-date="2020-05-04">27448</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-05-04"></transaction-date>
   <value currency="CAD" value-date="2020-05-04">82896</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-05-31"></transaction-date>
   <value currency="CAD" value-date="2020-05-31">-27448</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-05-31"></transaction-date>
   <value currency="CAD" value-date="2020-05-31">-82896</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-05-31"></transaction-date>
   <value currency="CAD" value-date="2020-05-31">27448</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-05-31"></transaction-date>
   <value currency="CAD" value-date="2020-05-31">82896</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-11-02"></transaction-date>
   <value currency="CAD" value-date="2020-11-02">27659</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-11-02"></transaction-date>
   <value currency="CAD" value-date="2020-11-02">83532</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-11-30"></transaction-date>
   <value currency="CAD" value-date="2020-11-30">-27659</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-11-30"></transaction-date>
   <value currency="CAD" value-date="2020-11-30">-83532</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-11-30"></transaction-date>
   <value currency="CAD" value-date="2020-11-30">27659</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-11-30"></transaction-date>
   <value currency="CAD" value-date="2020-11-30">83532</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-06-07"></transaction-date>
   <value currency="CAD" value-date="2021-06-07">27659</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-06-07"></transaction-date>
   <value currency="CAD" value-date="2021-06-07">83532</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Universit&#xE9; de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Grant is conditional on completion of specified terms of reference, receipt of specified deliverables</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de respecter le mandat &#xE9;tabli et de livrer les r&#xE9;sultats attendus</narrative>
   </condition>
   <condition type="3">
    <narrative xml:lang="EN">Grant is conditional on periodic submission of a detailed accounting of expenditure of funds received from IDRC accompanied by estimation of budget for the next reporting period</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de p&#xE9;riodiquement pr&#xE9;senter une justification d&#xE9;taill&#xE9;e de l&apos;utilisation des fonds vers&#xE9;s par le CRDI ainsi qu&apos;une estimation budg&#xE9;taire de la p&#xE9;riode de rapport suivante</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
